Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study

<div>Proportion of subjects with each of thirteen COVID-19 symptoms at day 1, 3, 7, 10, and 14 in the placebo and the hesperidin groups.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study 

Figure 4 | Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study 